New Autoimmune Treatments Raise Hope but Demand Rigorous Scrutiny

Scientists are racing to transform the treatment landscape for autoimmune diseases like rheumatoid arthritis, lupus, and multiple sclerosis through experimental therapies that reprogram the immune system rather than merely suppress it. While these advances promise hope for millions of Americans suffering from chronic conditions, a clear-eyed assessment is vital to avoid costly pitfalls that could strain families and undermine national healthcare priorities. Are We Trading One Set of Risks for Another? Autoimmune diseases represent a cruel paradox: the body’s defenses turn against itself. Current treatments focus on broadly dampening immune activity but often fail to provide lasting relief while exposing...